UA89408C2 - Тверда фармацевтична композиція пролонгованого вивільнення 1-(2,3,4-триметоксибензил)піперазину і спосіб її одержання - Google Patents
Тверда фармацевтична композиція пролонгованого вивільнення 1-(2,3,4-триметоксибензил)піперазину і спосіб її одержанняInfo
- Publication number
- UA89408C2 UA89408C2 UAA200714180A UAA200714180A UA89408C2 UA 89408 C2 UA89408 C2 UA 89408C2 UA A200714180 A UAA200714180 A UA A200714180A UA A200714180 A UAA200714180 A UA A200714180A UA 89408 C2 UA89408 C2 UA 89408C2
- Authority
- UA
- Ukraine
- Prior art keywords
- trimethoxybenzyl
- pharmaceutical composition
- sustained release
- piperazine
- solid pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Тверда фармацевтична композиція пролонгованого вивільнення, яка містить активний інгредієнт 1-(2,3,4-триметоксибензил)піперазин або фармацевтично прийнятну сіль 1-(2,3,4-триметоксибензил)піперазину, в поєднанні з щонайменше одним поліетиленоксидом і щонайменше одним змащувальним агентом, і один або більше фармацевтично прийнятних наповнювачів.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0504997A FR2885807B1 (fr) | 2005-05-18 | 2005-05-18 | Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
UA89408C2 true UA89408C2 (uk) | 2010-01-25 |
Family
ID=35583424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200714180A UA89408C2 (uk) | 2005-05-18 | 2006-02-13 | Тверда фармацевтична композиція пролонгованого вивільнення 1-(2,3,4-триметоксибензил)піперазину і спосіб її одержання |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1881831A1 (uk) |
EA (1) | EA013645B1 (uk) |
FR (1) | FR2885807B1 (uk) |
UA (1) | UA89408C2 (uk) |
WO (1) | WO2006123073A1 (uk) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0815602A2 (pt) * | 2007-08-08 | 2015-03-03 | Usv Ltd | Composições de liberação prolongada de trimetazidina e processo para a preparação das mesmas |
WO2009034541A2 (en) * | 2007-09-11 | 2009-03-19 | Ranbaxy Laboratories Limited | Controlled release pharmaceutical dosage forms of trimetazidine |
WO2010084397A2 (en) * | 2009-01-20 | 2010-07-29 | Micro Labs Limited | Modified release solid pharmaceutical compositions of trimetazidine and process thereof |
TR201001902A2 (tr) * | 2010-03-12 | 2011-04-21 | Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Uzatılmış salınımlı trimetazidin tablet |
EP2394644B1 (en) * | 2010-05-04 | 2014-07-09 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Trimetazidine Formulation With Different Release Profiles |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2717687B1 (fr) * | 1994-03-24 | 1996-06-14 | Adir | Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale. |
FR2802424B1 (fr) * | 1999-12-17 | 2002-02-15 | Adir | Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale |
EP1195160B1 (en) * | 2000-10-05 | 2009-09-16 | USV Ltd. | Sustained release trimetazidine pharmaceutical compositions and a method of their preparation |
FR2818549B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine |
AU2002356425A1 (en) * | 2001-11-21 | 2003-06-10 | Themis Laboratories Private Limited | A process for manufacture of a sustained release composition containing microbe |
-
2005
- 2005-05-18 FR FR0504997A patent/FR2885807B1/fr active Active
-
2006
- 2006-02-13 UA UAA200714180A patent/UA89408C2/uk unknown
- 2006-02-13 WO PCT/FR2006/050128 patent/WO2006123073A1/fr not_active Application Discontinuation
- 2006-02-13 EP EP06709507A patent/EP1881831A1/fr not_active Withdrawn
- 2006-02-13 EA EA200702386A patent/EA013645B1/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1881831A1 (fr) | 2008-01-30 |
FR2885807B1 (fr) | 2008-05-16 |
EA200702386A1 (ru) | 2008-04-28 |
WO2006123073A1 (fr) | 2006-11-23 |
EA013645B1 (ru) | 2010-06-30 |
FR2885807A1 (fr) | 2006-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA88477C2 (uk) | Композиція пелети пролонгованого вивільнення, яка містить праміпексол або його фармацевтично прийнятну сіль, спосіб її виготовлення і її застосування | |
MX2007002189A (es) | Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos. | |
TW200609005A (en) | Film-coated tablet with plural coating-layers | |
RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
EP1993567A4 (en) | PER OS ADMINISTRABLE GALLIUM PREPARATIONS AND METHODS OF USE | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
EP1589947B8 (en) | Pharmaceutical formulation with an insoluble active agent for pulmonary administration | |
TW200640487A (en) | Combination of XOLAIR with immunosuppressive agent | |
ZA200603538B (en) | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
TR200604349A2 (tr) | Aripiprazol içeren farmasötik bileşimler | |
SI1906916T1 (sl) | Oftalmična suspenzija, ki obsega oftalmično zdravilo, poloksamin in glikolno sredstvo za naravnavo toničnosti, uporaba sestavka za pripravo zdravila za zdravljenje oftalmičnih motenj | |
PT1121127E (pt) | Composicoes farmaceuticas orais contendo buprenorfina | |
UA89408C2 (uk) | Тверда фармацевтична композиція пролонгованого вивільнення 1-(2,3,4-триметоксибензил)піперазину і спосіб її одержання | |
WO2005007137A3 (de) | Ambroxolhaltige tabletten | |
MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
BR0112847A (pt) | Uso de uma forma de dosagem sólida | |
EP3949967A8 (en) | Solid pharmaceutical composition comprising tlr7 agonist | |
TW200509980A (en) | Parasiticidal composition | |
WO2007121471A3 (en) | Dialkyl ether delivery agents | |
JP2006527741A5 (uk) | ||
TW200621304A (en) | Pharmaceutical composition | |
GR1004331B (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος | |
MY158344A (en) | Oral drug delivery system | |
EP1842556A4 (en) | THERAPEUTIC AGENT FOR THE TREATMENT OF HYPERACTIVITY DISORDER WITH DEFICIT ATTENTION |